Accessibility Menu
Primemd logo

Primemd(OTC) PRMD

Market Cap$5.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1990)-100%
5 Year-100%
1 Year+50%
1 Month-73%
$0.00
+0.00%
+0.00Today
Primemd last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-10
Primemd stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-72.73%USD 0.002026-04-20
1 month-72.73%USD 0.002026-04-20
3 month-57.14%USD 0.002026-02-23
Year to date-40%USD 0.002025-12-23
1 year+50%USD 0.002024-12-27
3 year-72.73%USD 0.002023-06-30
5 year-99.9%USD 0.322021-07-09
Since inception-99.75%USD 0.121990-10-24

Primemd Financials at a Glance

Market Cap

$5.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$10.50M

Net Income (TTM)

$3.14M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-16.98 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

May 10, 2024

PRMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Primemd

PrimeMD Inc. is a healthcare-focused company engaged in the acquisition and development of residential and commercial real estate properties in the United States. Additionally, the company holds interests in oil and gas properties, positioning itself as a diversified entity in the medical care facilities industry.

Products and Services
  • Development of residential and commercial real estate properties
  • Investment in oil and gas properties
  • Healthcare facility management services
Growth Outlook
  • Recent quarterly revenue peaked at 4.6 million, indicating strong market demand
  • Trailing twelve months (TTM) net income margin stands at 29.9%, showcasing profitability
  • Current ratio of 16.52 suggests robust liquidity and financial health
Financial Highlights
  • Latest quarterly net income reached 2.6 million, reflecting operational efficiency
  • TTM return on equity is 73.34%, indicating effective use of shareholder funds
  • Debt ratio of 46.55% shows manageable leverage compared to industry standards
PrimeMD Inc. has demonstrated a solid financial performance, particularly in its most recent quarterly results, where it achieved a net income of 2.6 million. This performance is supported by a strong revenue stream, which peaked at 4.6 million, reflecting the company's ability to capitalize on market opportunities. The TTM net income margin of 29.9% underscores the company's operational efficiency and profitability. The company's liquidity position is robust, as indicated by a current ratio of 16.52, which suggests that PrimeMD Inc. is well-equipped to meet its short-term obligations. Furthermore, the impressive return on equity of 73.34% highlights the effective utilization of shareholder investments, making it an attractive option for potential investors. With a debt ratio of 46.55%, PrimeMD Inc. maintains a manageable level of leverage, positioning itself favorably within the industry. This combination of strong financial metrics and growth potential makes PrimeMD Inc. a noteworthy consideration for investors looking to explore opportunities in the healthcare and real estate sectors.
AI Generated • Jul 16, 2026

Industry

Real Estate Management and Development

CEO

Raymond N. Joeckel

Headquarters

Littleton, CO 80123, US

PRMD Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

39.60%

Net Income Margin

29.90%

Return on Equity

73.34%

Return on Capital

28.74%

Return on Assets

20.49%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

18.70M

Volume

1.00K

Avg. Volume

15.873

Financials (TTM)

Gross Profit

$10.50M

Operating Income

$4.10M

EBITDA

$4.03M

Operating Cash Flow

$3.02M

Capital Expenditure

-$772.47K

Free Cash Flow

$2.24M

Cash & ST Invst.

$2.59M

Total Debt

$7.13M

Primemd Performance Analysis

Primemd annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 10,501,684N/A
Primemd sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-03-31N/A
Q12021-06-30512.7%
Q22021-09-30-24.7%
Q32021-12-31-52.8%
Primemd annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.17N/A
Primemd sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-03-31N/A
Q12021-06-30-66.7%
Q22021-09-30-268.9%
Q32021-12-31796.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2021YOY CHG

Revenue

$1.64M

N/A

Gross Profit

$1.64M

N/A

Gross Margin

100.00%

N/A

Market Cap

$5.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$5.60K

N/A

Employees

1

N/A

Net Income

$2.63M

N/A

EBITDA

$3.40M

N/A

Quarterly Fundamentals

Name
Q3 2021YOY CHG

Total Cash

$2.59M

N/A

Total Debt

$7.13M

N/A

Accounts Receivable

$5.04M

N/A

Inventory

$0.00

N/A

Long Term Debt

$6.89M

N/A

Short Term Debt

$239.28K

N/A

Return on Assets

20.49%

N/A

Return on Invested Capital

27.98%

N/A

Free Cash Flow

$3.82M

N/A

Operating Cash Flow

$4.58M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ROTHPharmaRoth Labs, Inc.
$0.00+0.00%
IBXGiBX Group, Inc.
$0.00+0.00%
ITMCItoco Inc.
$0.00+0.00%
DECNDecision Diagnostics Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About PRMD

What is the current price of Primemd?

Primemd is trading at $0.00 per share.

What is the 52-week range for Primemd?

Over the past 52 weeks, Primemd has traded between $0.00 and $0.00.

How much debt does Primemd have?

As of the most recent reporting period, Primemd reported total debt of $7.13M.

How much cash does Primemd have on hand?

Primemd reported $2.59M in cash and cash equivalents in its most recent financial results.

What is Primemd’s dividend yield?

Primemd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.